DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Documents Drug Study

Drug’s Name RANITIDINE (Zantac) Classification Histamine₂ Blocker Indication Treatment and prevention of heartburn, acid indigestion, and sour stomach. Action Potent…

Documents Case Study Bipolar

L. F. Gonzales College of Science and Technology Institute Maharlika Highway, San Leonardo, Nueva Ecija Submitted by: Balajadia, Enrick D. Feliciano, Geruel D. Garcia, Patria…

Documents Drug Study

Medication Drug Class Gastroint estinal agent; hyperos motic laxative Indicatio n Preventio n and treatment of portalsystemic encephal opathy (PSE), including stages of hepatic…

Documents Neutrophil.PPT ....

Neutropenia is a blood disorder that can affect anyone. Some people are born with it. It can happen after a viral infection. In some cases the cause can be a side effect…

Documents FINAL DRUG STUDY.

ANTI-DEPRESSANTS 1. Sertraline (Zoloft) DRUGS Generic name: Sertraline INDICATION y Symptoms of depression in patients with or without history of mania. Obsessivecompulsive…

Documents ZAMORA - COLON CANCER 2

FAR EASTERN UNIVERSITY INSTITUTE OF NURSING RIZAL MEDICAL CENTER PASIG CITY CASE STUDY: COLON CANCER DRUG STUDY Generic Name / Trade Name Spironolactone Aldactone, Novospiroton†,…

Documents Drugs

Generic Name: Losartan Brand Name: Cozaar Classification: Anti-hypertensive: Angiotensin II Receptor Antagonist/Blocker Suggested Dosage: (PO) Hypertension- 50 mg OD initially…

Healthcare Azathioprine.ppt

1. AZATHIOPRINE 2. • Class: Immunosuppressive,an analogue of mercaptopurine • Action Suppresses cell-mediated hypersensitivities; alters antibody production and may reduce…

Documents Drug Study

DRUG STUDY DRUG’S NAME: Bisacodyl (Bisacodyl) Dose / Frequency : I tab po @hs x 2 doses Classification Mechanism of Action Stimulant laxative that increases peristalsis,…

Documents Diazepam, Lanoxin, Hemostan, Naprex.docx

Rene John G. Francisco BN4-A; Group 2 February 15, 2013 Drug Study (Diazepam, Lanoxin, Hemostan, Naprex) Name of the Drug Dosage/ Route/ Timing Mechanism of Action Indication…